Sandu Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Income

Operating income

65.35

65.50

58.76

48.37

49.42

Expenses

Material consumed

31.19

35.74

34.50

25.11

25.31

Manufacturing expenses

0.39

0.34

0.33

0.33

0.33

Personnel expenses

11.10

8.91

8.02

6.85

6.49

Selling expenses

-

-

-

-

-

Adminstrative expenses

20.18

17.63

13.75

14.62

15.20

Expenses capitalised

-

-

-

-

-

Cost of sales

62.86

62.63

56.60

46.91

47.33

Operating profit

2.49

2.87

2.16

1.46

2.09

Other recurring income

0.33

0.08

0.19

0.45

0.57

Adjusted PBDIT

2.82

2.96

2.35

1.91

2.67

Financial expenses

0.08

0.11

0.11

0.43

1.01

Depreciation

0.52

0.53

0.56

0.55

0.64

Other write offs

-

-

-

-

-

Adjusted PBT

2.22

2.32

1.68

0.92

1.02

Tax charges

0.70

0.73

0.59

0.20

0.35

Adjusted PAT

1.52

1.59

1.09

0.72

0.67

Non recurring items

-

-

-

-

-

Other non cash adjustments

-

-

-

-

-

Reported net profit

1.52

1.59

1.09

0.72

0.67

Earnigs before appropriation

8.20

6.56

4.36

3.13

2.28

Equity dividend

0.66

0.35

-

-

-

Preference dividend

-

-

-

-

-

Dividend tax

-

-

-

-

-

Retained earnings

7.54

6.21

4.36

3.13

2.28